R2M Pharma, Inc

Emerald Cloud Lab, located in South San Francisco, is a cutting-edge remote-controlled life science laboratory that offers highly automated services. Accessible from anywhere in the world, this innovative facility provides researchers with the ability to conduct experiments and analyze data without being physically present. Generated from their website's infomation

Novome Biotechnologies is a South San Francisco-based company that specializes in engineering living medicines for chronic diseases. Their innovative approach involves building cell therapies that are precise, extensible, and symbiotic with the patient, aiming to achieve long-term health. Novome's platform, GEMMs (Genetically Engineered Microbial Medicines), focuses on colonizing the gut with engineered microbes to deliver targeted therapeutic activities for sustained and effective treatments. With a strong emphasis on well-defined mechanisms of action and tunable treatment, Novome's therapies utilize highly-abundant gut microbes that are programmed with specific therapeutic functions. Their approach allows for convenient delivery through small, oral doses of a universal strain, making treatment safe, non-invasive, and tailored to specific conditions. Through their pipeline of programs, Novome aims to address a variety of diseases with clear etiology, including enteric hyperoxaluria, irritable bowel syndrome, and immuno-oncology.Generated from the website

Cureline is a global contract research organization (CRO) specializing in human biospecimen services, including biobanking and laboratory analysis, to support accelerated drug research and development since its inception in 2003. With a robust global clinical network and regulatory expertise, Cureline offers a diverse array of high-quality biospecimens and custom protocols tailored for various therapeutic areas, including oncology, infectious diseases, and neurological disorders. The company operates an extensive HBS biorepository located in the San Francisco Bay area, providing validated human biospecimens for biomarker development and translational research. Cureline has collaborated with over 150 clinical sites worldwide and has successfully completed projects for approximately 700 clients while actively participating in significant NIH scientific consortiums. Generated from the website